Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
Clinical trial NCT05705791 · TERMINATED
Trial details
- NCT number
- NCT05705791
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2024-07-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.